Mellaril-S en es it fr

Mellaril-S Brand names, Mellaril-S Analogs

Mellaril-S Brand Names Mixture

  • No information avaliable

Mellaril-S Chemical_Formula


Mellaril-S RX_link

Mellaril-S fda sheet

Mellaril-S msds (material safety sheet)

Mellaril-S MSDS

Mellaril-S Synthesis Reference

Bourquin et al., Helv. Chim. Acta 41, 1072 (1958)

Mellaril-S Molecular Weight

370.577 g/mol

Mellaril-S Melting Point

73 oC

Mellaril-S H2O Solubility

0.0336 mg/L

Mellaril-S State


Mellaril-S LogP


Mellaril-S Dosage Forms

Suspension; Tablet

Mellaril-S Indication

For the treatment of schizophrenia and generalized anxiety disorder.

Mellaril-S Pharmacology

Thioridazine is a trifluoro-methyl phenothiazine derivative intended for the management of schizophrenia and other psychotic disorders. Thioridazine has not been shown effective in the management of behaviorial complications in patients with mental retardation.

Mellaril-S Absorption


Mellaril-S side effects and Toxicity

LD50=956-1034 mg/kg (Orally in rats); Agitation, blurred vision, coma, confusion, constipation, difficulty breathing, dilated or constricted pupils, diminished flow of urine, dry mouth, dry skin, excessively high or low body temperature, extremely low blood pressure, fluid in the lungs, heart abnormalities, inability to urinate, intestinal blockage, nasal congestion, restlessness, sedation, seizures, shock

Mellaril-S Patient Information

Mellaril-S Organisms Affected

Humans and other mammals